Sigma-Aldrich to Acquire
Proligo; Shelves India Facility

Sigma-Aldrich plans to purchase DNA and RNA maker Proligo from Degussa, the company said this week.

Proligo, headquartered in Boulder, Colo., provides custom DNA, RNA, and raw materials for DNA and RNA synthesis. The company is one of four exclusive licensees to an RNAi patent application owned by MIT.

Last year, Proligo had approximately $40 million in sales. The 300-employee company has manufacturing sites in Boulder, France, Germany, Singapore, Japan, and Australia.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.